sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Lithium citrate

Lithium citrate

CAS No.:
6080-58-6
Catalog Number:
AG00IAR4
Molecular Formula:
C6H13Li3O11
Molecular Weight:
281.9838
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
99%
In Stock USA
United States
$39
- +
5g
99%
In Stock USA
United States
$57
- +
25g
99%
In Stock USA
United States
$112
- +
Product Description
Catalog Number:
AG00IAR4
Chemical Name:
Lithium citrate
CAS Number:
6080-58-6
Molecular Formula:
C6H13Li3O11
Molecular Weight:
281.9838
MDL Number:
MFCD00012461
IUPAC Name:
trilithium;2-hydroxypropane-1,2,3-tricarboxylate;tetrahydrate
InChI:
InChI=1S/C6H8O7.3Li.4H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;4*1H2/q;3*+1;;;;/p-3
InChI Key:
HXGWMCJZLNWEBC-UHFFFAOYSA-K
SMILES:
[O-]C(=O)C(CC(=O)[O-])(CC(=O)[O-])O.[Li+].[Li+].[Li+].O.O.O.O
EC Number:
612-032-8
UNII:
5Z6E9K79YV
Properties
Complexity:
211  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
8  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
282.094g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
11  
Hydrogen Bond Donor Count:
5  
Isotope Atom Count:
0
Molecular Weight:
281.979g/mol
Monoisotopic Mass:
282.094g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
145A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
A computerised sampling strategy for therapeutic drug monitoring of lithium provides precise estimates and significantly reduces dose-finding time. Basic & clinical pharmacology & toxicology 20120301
Lithium citrate as treatment of Canavan disease. Clinical neuropharmacology 20120101
Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate. Cancer biology & therapy 20110201
Scanning probe direct-write of germanium nanostructures. Advanced materials (Deerfield Beach, Fla.) 20101102
Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20100701
[Use of lithium in the Norwegian counties Oslo and Sogn og Fjordane]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20090430
Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology 20090201
[The problem of poisoning with lithium compounds--the past and the present]. Sudebno-meditsinskaia ekspertiza 20080101
Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar disorders 20071101
Ground, sieved, and C18 modified monolithic silica particles for packing material of microcolumn high-performance liquid chromatography. Journal of chromatography. A 20070316
Manic delirium associated with clomiphene-induced ovulation. Psychosomatics 20070101
[The discovery of therapeutic properties of lithium]. Vertex (Buenos Aires, Argentina) 20060101
Lithium citrate for Canavan disease. Pediatric neurology 20051001
Visual compatibility of risperidone solution and lithium citrate syrup. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030315
Long-term effects of lithium on the kidney: functional-morphological correlations. Journal of psychiatric research 19890101
Properties